52

Ishita Drugs and Industries LtdBOM 524400 Stock Report

Last reporting period 30 Sep, 2023

Updated 31 Oct, 2024

Last price

Market cap $B

0.002

Micro

Exchange

XBOM - Bombay Stock Exchange

524400.BO Stock Analysis

52

Uncovered

Ishita Drugs and Industries Ltd is uncovered by Eyestock quantitative analysis.

Market cap $B

0.002

Dividend yield

Shares outstanding

2.99 B

Ishita Drugs & Industries Ltd. engages in the manufacturing of basic drugs. The company is headquartered in Ahmedabad, Gujarat. The firm's APIs include sulpha drugs/sulfonamides, vitamins, fluoroquinolones, antibiotics, anthelmintics, iodides and citrates (salts), food additive/excipients, and others. Its drug intermediates include 4- Sulfonamido Phenyl Hydrazine Hydrochloride (Celecoxib Intermediate), 4- Chloro Phenyl Hydrazine Hydrochloride (intermediate for Indole Carboxylic Acid), L-Alanine Benzylester Tosylate, 5 Cyano Phthalide (Citalopram Intermediate), Indole 2 Carboxylic Acid, Ethyl 3-Benzoyl Acrylate, Hexa Methyl Disilazane, 5-Chloromethopabate, Indole 2 Carboxylic Acid, and others. Its fine chemicals include salicylanilide, para bromo toluene, pyridine hydrobromide, potassium phthalimide, nicotinic acid hydrazide, 3 amino pyridine, methyl iodide. Its products are exported to various countries across the world.

View Section: Eyestock Rating